Hansa Biopharma

Presence

Hansa Biopharma is a company listed under the stock ticker HNSA (SE).

Executives

View the org chart displaying its 19 main executives

Most searched biographies at Hansa Biopharma
Popular executive movements at Hansa Biopharma
  • Evan Ballantyne will join the company as Chief Financial Officer on Mar. 1, 2024  (posted on February 23 2024).
  • Donato Spota, Senior Vice President and Chief Financial Officer, will leave the company on Feb. 28, 2024  (posted on November 27 2023).
  • Hitto Kaufmann has joined the company as Chief Scientific Officer  (posted on September 1 2023).

Create your alert
to follow the executive moves at Hansa Biopharma.

Biotechnology

Hansa Biopharma has 2,279 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry >

News

Press releases by Hansa Biopharma
Social media about Hansa Biopharma

Get in Touch

Contact by email its executives including Peter Nicklin Premium

Call Hansa Biopharma at +46 ...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Executive Data Sets
Executives
Companies
The Official Board